Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""The Journal of Urology"" wg kryterium: JN


Tytuł :
The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance.
Autorzy :
Gregg JR; University of Texas MD Anderson Cancer Center, Houston, Texas.
Surasi DS; University of Texas MD Anderson Cancer Center, Houston, Texas.
Childs A; University of Texas MD Anderson Cancer Center, Houston, Texas.
Moll N; University of Texas MD Anderson Cancer Center, Houston, Texas.
Ward JF; University of Texas MD Anderson Cancer Center, Houston, Texas.
Kim J; Merck & Co., Inc., Kenilworth, New Jersey.
Daniel CR; University of Texas MD Anderson Cancer Center, Houston, Texas.
Logothetis C; University of Texas MD Anderson Cancer Center, Houston, Texas.
Bathala T; University of Texas MD Anderson Cancer Center, Houston, Texas.
Davis JW; University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Jan; Vol. 205 (1), pp. 122-128. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Adiposity/*physiology
Intra-Abdominal Fat/*physiopathology
Prostate/*pathology
Prostatic Neoplasms/*mortality
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy/statistics & numerical data ; Disease Progression ; Follow-Up Studies ; Humans ; Intra-Abdominal Fat/diagnostic imaging ; Kallikreins/blood ; Magnetic Resonance Imaging/statistics & numerical data ; Male ; Middle Aged ; Neoplasm Grading ; Organ Size ; Progression-Free Survival ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Subcutaneous Fat/diagnostic imaging ; Subcutaneous Fat/physiopathology
Czasopismo naukowe
Tytuł :
PI-RADS® Category as a Predictor of Progression to Unfavorable Risk Prostate Cancer in Men on Active Surveillance.
Autorzy :
Wang AZ; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
O’Conno LP; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Yerram NK; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Long L; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Zeng J; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Mehralivand S; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Harmon SA; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland.
Lebastchi AH; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Ahdoot M; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Gomella PT; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Choyke PL; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Merino MJ; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Shih JH; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Wood BJ; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1229-1235. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Magnetic Resonance Imaging, Interventional/*statistics & numerical data
Multiparametric Magnetic Resonance Imaging/*statistics & numerical data
Prostate/*diagnostic imaging
Prostatic Neoplasms/*pathology
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy, Large-Core Needle/statistics & numerical data ; Disease Progression ; Humans ; Image-Guided Biopsy/statistics & numerical data ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Grading/statistics & numerical data ; Progression-Free Survival ; Prospective Studies ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/mortality ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
Autorzy :
Maggi M; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Department of Urology, Sapienza Rome University, Rome, Italy.
Cowan JE; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Fasulo V; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Department of Urology, Istituto Clinico Humanitas IRCCS-Clinical and Research Hospital, Rozzano, Milan, Italy.
Washington SL 3rd; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Epidemiology & Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Lonergan PE; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Sciarra A; Department of Urology, Sapienza Rome University, Rome, Italy.
Nguyen HG; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Carroll PR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1222-1228. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Kallikreins/*blood
Prostate/*pathology
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*pathology
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy, Large-Core Needle/statistics & numerical data ; Disease-Free Survival ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/statistics & numerical data ; Magnetic Resonance Imaging, Interventional ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Grading/statistics & numerical data ; Neoplasm Metastasis ; Prognosis ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate/surgery ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/surgery ; Retrospective Studies ; Risk Assessment/statistics & numerical data ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging.
Autorzy :
Connor MJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Eldred-Evans D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
van Son M; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Hosking-Jervis F; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Bertoncelli Tanaka M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Reddy D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Bass EJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Powell L; Department of Urology, St. George's Hospital NHS Foundation Trust, London, United Kingdom.
Ahmad S; Department of Urology, Epsom and St. Helier's University Hospital Trust, Surrey, United Kingdom.
Pegers E; RM Partners, West London Cancer Alliance, Royal Marsden Hospital, London, United Kingdom.
Joshi S; RM Partners, West London Cancer Alliance, Royal Marsden Hospital, London, United Kingdom.
Sri D; Department of Urology, St. George's Hospital NHS Foundation Trust, London, United Kingdom.
Wong K; Department of Urology, Epsom and St. Helier's University Hospital Trust, Surrey, United Kingdom.
Tam H; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Hrouda D; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Qazi H; Department of Urology, St. George's Hospital NHS Foundation Trust, London, United Kingdom.
Gordon S; Department of Urology, Epsom and St. Helier's University Hospital Trust, Surrey, United Kingdom.
Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1195-1201. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostate/*pathology
Prostatic Neoplasms/*diagnosis
Aged ; Biopsy, Large-Core Needle/methods ; Biopsy, Large-Core Needle/statistics & numerical data ; Humans ; Image-Guided Biopsy/methods ; Image-Guided Biopsy/statistics & numerical data ; Kallikreins/blood ; Male ; Middle Aged ; Perineum/surgery ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer.
Autorzy :
Lonergan PE; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Washington SL 3rd; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Cowan JE; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Zhao S; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Nguyen HG; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Shinohara K; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Cooperberg MR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California.
Carroll PR; Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1216-1221. Date of Electronic Publication: 2020 Jun 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Kallikreins/*blood
Prostate/*pathology
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*diagnosis
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy, Large-Core Needle/statistics & numerical data ; Disease Progression ; Humans ; Image-Guided Biopsy/statistics & numerical data ; Magnetic Resonance Imaging, Interventional ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Grading/statistics & numerical data ; Prospective Studies ; Prostate/diagnostic imaging ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk Assessment/statistics & numerical data ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective Studies.
Autorzy :
Park KJ; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Choi SH; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JS; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Clinical Research Center, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim JK; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim MH; Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Jeong IG; Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1141-1149. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Magnetic Resonance Imaging, Interventional*
Prostate/*pathology
Prostatic Neoplasms/*diagnosis
Biopsy, Large-Core Needle/methods ; Critical Pathways ; Feasibility Studies ; Humans ; Image-Guided Biopsy/methods ; Male ; Prospective Studies ; Prostate/diagnostic imaging ; Prostatic Neoplasms/epidemiology ; Prostatic Neoplasms/pathology ; Risk Assessment/methods ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł :
How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
Autorzy :
Song G; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
Ruan M; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
Wang H; Department of Radiology, Peking University First Hospital, Beijing, China.
Fan Y; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
He Q; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
Lin Z; Department of Radiology, Peking University First Hospital, Beijing, China.
Li X; Department of Statistics, Peking University First Hospital, Beijing, China.
Li P; Department of Ultrasound, Peking University First Hospital, Beijing, China.
Wang X; Department of Radiology, Peking University First Hospital, Beijing, China.
He Z; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
Zhou L; Department of Urology, Peking University First Hospital, Beijing, China.; Institute of Urology, Peking University, Beijing, China.; National Urological Cancer Center of China, Beijing, China.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1202-1208. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Practice Guidelines as Topic*
Biopsy, Large-Core Needle/*standards
Image-Guided Biopsy/*standards
Prostate/*pathology
Prostatic Neoplasms/*diagnosis
Aged ; Biopsy, Large-Core Needle/methods ; Biopsy, Large-Core Needle/statistics & numerical data ; Humans ; Image-Guided Biopsy/methods ; Image-Guided Biopsy/statistics & numerical data ; Kallikreins/blood ; Magnetic Resonance Imaging, Interventional ; Male ; Middle Aged ; Multimodal Imaging/methods ; Perineum/surgery ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł :
Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy.
Autorzy :
Kinnaird A; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Sharma V; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Chuang R; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Priester A; Department of Bioengineering, University of California at Los Angeles, Los Angeles, California.
Tran E; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Barsa DE; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Delfin M; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Kwan L; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Sisk A; Department of Pathology & Laboratory Medicine, University of California at Los Angeles, Los Angeles, California.
Felker E; Department of Radiological Sciences, University of California, Los Angeles, California.
Marks LS; Department of Urology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1180-1186. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Magnetic Resonance Imaging, Interventional/*statistics & numerical data
Multimodal Imaging/*statistics & numerical data
Prostate/*pathology
Prostatic Neoplasms/*epidemiology
Aged ; Biopsy, Large-Core Needle/standards ; Biopsy, Large-Core Needle/statistics & numerical data ; False Negative Reactions ; Humans ; Image-Guided Biopsy/standards ; Image-Guided Biopsy/statistics & numerical data ; Incidence ; Magnetic Resonance Imaging, Interventional/standards ; Male ; Middle Aged ; Multimodal Imaging/standards ; Practice Guidelines as Topic ; Predictive Value of Tests ; Prostate/diagnostic imaging ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Reproducibility of Results ; Risk Assessment/statistics & numerical data ; Ultrasonography, Interventional/standards ; Ultrasonography, Interventional/statistics & numerical data
Czasopismo naukowe
Tytuł :
Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?
Autorzy :
Deniffel D; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Salinas E; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Ientilucci M; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Evans AJ; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Fleshner N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Ghai S; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Hamilton R; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Roberts A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
Toi A; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
van der Kwast T; Department of Pathology, Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Zlotta A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Surgery, Division of Urology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Finelli A; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Haider MA; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.; Joint Department of Medical Imaging, University Health Network/Sinai Health System, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Perlis N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1187-1194. Date of Electronic Publication: 2020 Jun 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Magnetic Resonance Imaging, Interventional/*statistics & numerical data
Multiparametric Magnetic Resonance Imaging/*statistics & numerical data
Prostate/*diagnostic imaging
Prostatectomy/*statistics & numerical data
Prostatic Neoplasms/*mortality
Aged ; Biopsy, Large-Core Needle/methods ; Biopsy, Large-Core Needle/statistics & numerical data ; Disease Progression ; Disease-Free Survival ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/methods ; Image-Guided Biopsy/statistics & numerical data ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Grading ; Prostate/pathology ; Prostate/surgery ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/surgery ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Editorial Comment.
Autorzy :
Te AE; Department of Urology, Weill Medical College of Cornell University, Urology Program of the Iris Cantor Men's Health Center, New York Presbyterian Cornell, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 1010. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Lower Urinary Tract Symptoms*
Prostate*
Humans ; Male ; Referral and Consultation ; Surveys and Questionnaires ; Urinary Bladder
Czasopismo naukowe
Tytuł :
Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy.
Autorzy :
Chuang R; Department of Urology, University of California, Los Angeles, California.
Kinnaird A; Department of Urology, University of California, Los Angeles, California.
Kwan L; Department of Urology, University of California, Los Angeles, California.
Sisk A; Department of Pathology, University of California, Los Angeles, California.
Barsa D; Department of Urology, University of California, Los Angeles, California.
Felker E; Department of Radiology, University of California, Los Angeles, California.
Delfin M; Department of Urology, University of California, Los Angeles, California.
Marks L; Department of Urology, University of California, Los Angeles, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 941-949. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Aftercare/*methods
Cryosurgery/*methods
Prostate/*pathology
Prostatic Neoplasms/*surgery
Aftercare/statistics & numerical data ; Aged ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/adverse effects ; Image-Guided Biopsy/methods ; Image-Guided Biopsy/statistics & numerical data ; Kallikreins/blood ; Magnetic Resonance Imaging, Interventional ; Male ; Neoplasm Grading ; Prospective Studies ; Prostate/diagnostic imaging ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The Prognostic Impact of Intraductal Carcinoma of the Prostate: A Systematic Review and Meta-Analysis.
Autorzy :
Miura N; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
Mostafaei H; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
Motlagh RS; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Hospital of Tours, Tours, France.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
D'Andrea D; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Saika T; Department of Urology, Ehime University Graduate School of Medicine, Ehime, Japan.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.; Department of Urology, Weill Cornell Medical College, New York, New York.; Department of Urology, University of Texas Southwestern, Dallas, Texas.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.; Department of Urology, University of Jordan, Amman, Jordan.; European Association of Urology Research Foundation, Arnhem, The Netherlands.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 909-917. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Prostatectomy*
Carcinoma, Intraductal, Noninfiltrating/*mortality
Neoplasm Recurrence, Local/*epidemiology
Prostate/*pathology
Prostatic Neoplasms/*mortality
Biopsy ; Carcinoma, Intraductal, Noninfiltrating/blood ; Carcinoma, Intraductal, Noninfiltrating/diagnosis ; Carcinoma, Intraductal, Noninfiltrating/therapy ; Clinical Decision-Making ; Disease-Free Survival ; Humans ; Kallikreins/blood ; Male ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Prognosis ; Prostate/surgery ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Impact of Biopsy Compliance on Outcomes for Patients on Active Surveillance for Prostate Cancer.
Autorzy :
Detsky JS; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Ghiam AF; University Health Network, Toronto, Ontario, Canada.
Mamedov A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Commisso K; Department of Radiation Oncology, BC Cancer Agency, Victoria, British Columbia, Canada.; University Health Network, Toronto, Ontario, Canada.
Commisso A; Department of Radiation Oncology, BC Cancer Agency, Victoria, British Columbia, Canada.; University Health Network, Toronto, Ontario, Canada.
Zhang L; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Liu S; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Klotz L; Division of Urology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Loblaw A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Vesprini D; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 934-940. Date of Electronic Publication: 2020 Apr 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local/*epidemiology
Patient Compliance/*statistics & numerical data
Prostate/*pathology
Prostatic Neoplasms/*therapy
Watchful Waiting/*statistics & numerical data
Aged ; Biopsy/statistics & numerical data ; Disease Progression ; Disease-Free Survival ; Follow-Up Studies ; Humans ; Kallikreins/blood ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/prevention & control ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/mortality ; Retrospective Studies ; Watchful Waiting/methods
Czasopismo naukowe
Tytuł :
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
Autorzy :
Ranasinghe W; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Reichard CA; University of Texas M.D. Anderson Cancer Center, Houston, Texas.; Urology of Indiana, Indianapolis, Indiana.
Nyame YA; University of Washington Medical Center, Seattle, Washington.
Sundi D; The Ohio State University, James Cancer Hospital, Columbus, Ohio.
Tosoian JJ; University of Michigan, Ann Arbor, Michigan.
Wilkins L; Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Alam R; Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland.
Achim MF; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Wang X; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Stephenson AJ; Rush University, Chicago, Illinois.
Klein EA; Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Ross AE; Texas Oncology, Dallas, Texas.
Allaf ME; Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland.
Davis JW; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Chapin BF; University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Oct; Vol. 204 (4), pp. 748-753. Date of Electronic Publication: 2020 Apr 07.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Prostatectomy*/methods
Prostate/*pathology
Prostate/*surgery
Prostatic Neoplasms/*pathology
Prostatic Neoplasms/*surgery
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Retrospective Studies ; Risk Assessment
Czasopismo naukowe
Tytuł :
Re: The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate BiopsiesA. Amin, M. J. Scheltema, R. Shnier, A. Blazevski, D. Moses, T. Cusick, A. Siriwardena, B. Yuen, P. J. van Leeuwen, A. M. Haynes, J. Matthews, P. Brenner, G. O'Neill, C. Yuen, W. Delprado, P. Stricker and J. Thompson J Urol 2020; 203: 910-917.
Autorzy :
Montorsi F; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Gandaglia G; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Fossati N; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Briganti A; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Oct; Vol. 204 (4), pp. 843. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Letter; Comment
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostate*
Biopsy ; Magnetic Resonance Imaging ; Male ; Watchful Waiting
Opinia redakcyjna
Tytuł :
Urine Extracellular Vesicle GATA2 mRNA Discriminates Biopsy Result in Men with Suspicion of Prostate Cancer.
Autorzy :
Woo J; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Santasusagna S; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Banks J; Division of Biostatistics and Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Pastor-Lopez S; Urology Department, Hospital Sant Jaume Calella, Barcelona, Spain.
Yadav K; Urology Department, Icahn School of Medicine at Mount Sinai, New York, New York.
Carceles-Cordon M; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Dominguez-Andres A; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Den RB; Radiation Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Languino LR; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Pippa R; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lallas CD; Urology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lu-Yao G; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Kelly WK; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Knudsen KE; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Rodriguez-Bravo V; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Tewari AK; Urology Department, Icahn School of Medicine at Mount Sinai, New York, New York.
Prats JM; Urology Department, Hospital Sant Jaume Calella, Barcelona, Spain.
Leiby BE; Division of Biostatistics and Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Gomella LG; Urology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Domingo-Domenech J; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Oct; Vol. 204 (4), pp. 691-700. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
MeSH Terms :
Extracellular Vesicles/*chemistry
GATA2 Transcription Factor/*genetics
Prostate/*pathology
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*pathology
RNA, Messenger/*analysis
Aged ; Aged, 80 and over ; Biopsy ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł :
High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.
Autorzy :
Abreu AL; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Peretsman S; Urology Specialists of the Carolinas, Charlotte, North Carolina.
Iwata A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shakir A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Iwata T; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Brooks J; Urology Specialists of the Carolinas, Charlotte, North Carolina.
Tafuri A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.; Urology Specialists of the Carolinas, Charlotte, North Carolina.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Department of Urology, University of Verona, Verona, Italy.
Ashrafi A; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Park D; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Cacciamani GE; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Kaneko M; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.; Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Duddalwar V; Departments of Radiology Keck School of Medicine, University of Southern California, Los Angeles, California.
Aron M; Departments of Pathology Keck School of Medicine, University of Southern California, Los Angeles, California.
Palmer S; Departments of Radiology Keck School of Medicine, University of Southern California, Los Angeles, California.
Gill IS; USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Oct; Vol. 204 (4), pp. 741-747. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Journal Article
MeSH Terms :
High-Intensity Focused Ultrasound Ablation/*methods
Prostate/*surgery
Prostatic Neoplasms/*surgery
Aged ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies